Floatz logo

FLUOROURACILUM

Squamous Cell Carcinoma of the Vulva

Tarveda TherapeuticsSmall moleculePhase 1/2Dormant
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

15 Active assets in the Squamous Cell Carcinoma of the Vulva cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Christian Hinrichs
Phase 2B
e7 tcr-t cells
Christian Hinrichs
Phase 2B
Fludarabine
Christian Hinrichs
Phase 2B
Atezolizumab
M.D. Anderson Cancer Center
Phase 2CCC
Nivolumab
National Cancer Institute (NCI)
Phase 2CCC

View all 19 →

Same molecule, other indications

FLUOROURACILUM is also rated in:

colon carcinomaDormant
A
Indicative ·
82 / 100
View asset →
Unresectable or Metastatic Colorectal CancerDormant
BBB
Indicative ·
79 / 100
View asset →
exocrine pancreatic carcinomaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →